Carbilev 25mg/250mg and 25 mg/250 mg Tablets.
PDF Leaflet Revision Date: 24 December 2020
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of Parkinsonu2019s disease and syndrome.
Dosage (summary)
Start with 1 tablet of CARBILEV 25/100 three times daily; max 8 tablets daily.
Special Populations
- Renal impairment
- Hepatic impairment
- Cardiovascular disease
- Paediatric population
Pregnancy & Breastfeeding
Not recommended in pregnancy; may inhibit lactation.
Key Drug Interactions
- MAO inhibitors
- Antihypertensives
- Antidepressants
- Anticholinergics
- Iron
Contraindications
- Hypersensitivity to carbidopa/levodopa
- Severe psychoses
- Closed-angle glaucoma
- History of malignant melanoma
Common side effects
- Dyskinesias
- Nausea
- Dizziness
- Somnolence
Counselling Points
- Monitor for sudden sleep onset
- Avoid driving until effects are known
- Gradual dosage reduction when discontinuing
Serious warnings
- Risk of neuroleptic malignant syndrome
- Impulse control disorders
- Dopamine Dysregulation Syndrome
Important Disclaimer
The Carbilev 25mg/250mg and 25 mg/250 mg Tablets. professional information leaflet below is the property of Pharmacare Ltd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
